Loss of expression of TGF-βs and their receptors in chronic skin lesions induced by sulfur mustard as compared with chronic contact dermatitis patients

BMC Dermatology

Volumn 11, Issue , 2011, Pages

  Khaheshi, Isa ^a,b   Keshavarz, Saeed ^a   Imani Fooladi, Abbas A ^a   Ebrahimi, Majid ^a   Yazdani, Samaneh ^a   Panahi, Yunes ^a   Shohrati, Majid ^a   Nourani, Mohammad R ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

MUSTARD GAS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; CHEMICAL WARFARE AGENT; IRRITANT AGENT; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TGFB1 PROTEIN, HUMAN; TGFB2 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; VICTIM; CHEMICAL BURN; CHEMICAL WARFARE; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG EFFECT; EPIDERMIS; GENE EXPRESSION; GENETICS; INFLAMMATION; IRAN; METABOLISM; MIDDLE AGED; PRURITUS; SKIN ALLERGY; SOLDIER;

ADULT; AGED; BURNS, CHEMICAL; CHEMICAL WARFARE; CHEMICAL WARFARE AGENTS; CHRONIC DISEASE; DERMATITIS, ALLERGIC CONTACT; EPIDERMIS; GENE EXPRESSION; HUMANS; INFLAMMATION; IRAN; IRRITANTS; MALE; MIDDLE AGED; MILITARY PERSONNEL; MUSTARD GAS; PROTEIN-SERINE-THREONINE KINASES; PRURITUS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 78651365812     PISSN: None     EISSN: 14715945     Source Type: Journal    
DOI: 10.1186/1471-5945-11-2     Document Type: Article

References (63)

1. Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005, 214(3):198-209. 10.1016/j.tox.2005.06.014, 16084004.
2. Khateri S, et al. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003, 45(11):1136-43. 10.1097/01.jom.0000094993.20914.d1, 14610394.
3. Goodman LS, et al. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. JAMA 1984, 251:2255-2261. 10.1001/jama.251.17.2255, 6368885.
4. Papirmeister B, et al. Pathology produced by sulfur mustard in human skin grafts on athymic nude mice II. J Toxicol 1984, 3:393-408.
5. Marrs TC, Maynard RL, Sidell FR. Chemical Warfare Agents. Toxicology and Treatment, Chichester 1996,
6. Khateri S, Ghanei M, Keshavarz S, et al. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003, 45:1136-1143. 10.1097/01.jom.0000094993.20914.d1, 14610394.
7. Somani SM. Chemical Warfare Agents. 1992, New York: Academic Press.
8. Petrali JP, Oglesby SB, Justus TA. Morphologic effects of sulfur mustard on a human skin equivalent. J. Toxicol. Cutaneous Ocul. Toxicol 1991, 10:315-324.
9. Momeni AZ, Enshaeih SH, Meghdadi M, et al. Skin manifestations of mustard gas A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992, 128:775-780. 10.1001/archderm.128.6.775, 1599263.
10. Hefazi M, Maleki M, Mahmoudi M, et al. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure. Int J Dermatol 2006, 45:1025-1031. 10.1111/j.1365-4632.2006.03020.x, 16961503.
11. Weisshaar E, Diepgen TL. Pruritus and quality of life. J Invest Dermatol 2005, 125:855-855.
12. Skoet R, Zachariae R, Agner T. Contact dermatitis and quality of life: A structured review of the literature. Br J Dermatol 2003, 149:452-456. 10.1046/j.1365-2133.2003.05601.x, 14510974.
13. Arroyo CM, Schafer RJ, Kurt EM, Broomfield CA, Carmichael AJ. Response of normal human keratinocytes to sulfur mustard: Cytokine release. J Appl Toxicol 2000, 20:63-72.
14. Ricketts KM, Santai CT, France JA, et al. Inflammatory cytokine response in sulfur mustard-exposed mouse skin. J Appl Toxicol 2000, 20:73-76.
15. Sabourin CL, Petrali JP, Casillas RP. Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin. J Biochem Mol Toxicol 2000, 14:291-302. 10.1002/1099-0461(2000)14:6<291::AID-JBT1>l3.0.CO;2-B, 11083082.
16. Hunter J, et al. Clinical Dermatology. 2002, 2:18-28. 3, 3: 37-38, 7: 70..
17. Thestrup-Pedersen K, Larsen CG, Ronnevig J. The immunology of contact dermatitis: A review with special refrences to the pathophysiology of eczema. Contact dermatitis 1989, 20:81. 10.1111/j.1600-0536.1989.tb03113.x, 2650994.
18. Nozaki S, Feliciani C, Sauder D. Keratinocyte cytokines In Advances in Dermatology. St. Louis: Mosby Year Book 1991.
19. Clark DA, Coker R. Transforming growth factor-beta (TGF-β). Int J Biochem Cell Biol 1998, 30:293-298. 10.1016/S1357-2725(97)00128-3, 9611771.
20. Roberts AB. Molecular and cell biology of TGF-β. Miner Electrolyte Metab 1998, 24:111-119. 10.1159/000057358, 9525693.
21. Wrana JL. TGF-β receptors and signaling mechanisms. Miner Electrolyte Metba 1998, 24:120-130.
22. Derynk R, Zhang Y, Feng XH, Smads. Transcriptional activators of TGF-beta responses. Cell 1998, 95:737-40. 10.1016/S0092-8674(00)81696-7, 9865691.
23. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathway in TGF-beta family signalling. Nature 2003, 425:577-84. 10.1038/nature02006, 14534577.
24. Moustakas A. Smad signalling network. J Cell Sci 2002, 115:3355-6.
25. Souchelnytskyi S, Rönnstrand L, Heldin CH, Tendijke P. Phosphorylation of Smad signaling proteins by receptor serine/threonine kinases. Methods Mol Biol 2001, 124:107-20.
26. Wrana J, et al. Mechanism of activation of the TGF-β receptor. Nature 1994, 370:341-7. 10.1038/370341a0, 8047140.
27. Nakao A, Imamura T, Souchelnytskyi S. TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. J EMBO 1997, 16:5353-62.
28. Abbus AK, et al. Cellular and Molecular Immunology. 2003, 11:249-265. 6, 268-271.
29. Kumar V, et al. Robbins Basic Pathology. 2007, 3:63-65. 8.
30. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998, 16:137-61. 10.1146/annurev.immunol.16.1.137, 9597127.
31. Gorelik L, Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2002, 2:46-53. 10.1038/nri704, 11905837.
32. Bogand C, Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleujin-10. Ann Ny Acad Sci 1993, 685:713-39. 10.1111/j.1749-6632.1993.tb35934.x, 8363277.
33. Geissmann F, Revy P, Regnault A, et al. TGF-beta 1 prevents the noncognate maturation of human dendritic langerhans cells. J Immunol 1999, 162:4567-75.
34. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4 + CD25 - naive T cells to CD4 + CD25 + regularatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-86. 10.1084/jem.20030152, 2194145, 14676299.
35. Kulkarni AB, huh C-G, Becker D, Geiser A, Lyght, Flanders KC, Roberts AB, Sporn MB, Ward JM. Transforming growth factor 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci 1993, 90:770-774. 10.1073/pnas.90.2.770, 45747, 8421714.
36. Sellheyer K, Bickenbach JR, Rothangel JA, Bundman D, Longley MA, Krieg T, Roche N, Roberts AB, Roop DR. Inhibition of skin development by overexpression of transforming growth factor β 1 in the epidermis of transgenic mice. Pro Natl Acad Sci 1993, 90:5237-5241.
37. Malkani AK, Baker BS, Garioch JJ, powels AV, Lewise HM, Valdimarsson H, Fry L. Normal response to tumor necrosis factor-α and transforming growth factor-β by keratinocytes in psoriasis. Exp Dermatol 1993, 2:224-230. 10.1111/j.1600-0625.1993.tb00037.x, 8162342.
38. Gambichler T, Tomi NS, Skrygan M, et al. Alterations of TGF-beta/Smad mRNA expression in atopic dermatitis following narrow-band ultraviolet B phototherapy: results of a pilot study. J Dermatol Sci 2006, 44:56-8. 10.1016/j.jdermsci.2006.06.004, 16889943.
39. Nourani MR, Owada Y, Kitanaka N, Abdelwahab SA, Iwasa H, Sakagami H, Spener F, Kondo H. Localization of epidermal-type fatty acid binding protein in macrophages in advanced atretic follicles of adult mice. J Mol Histol 2005, 36(6-7):391-400. 10.1007/s10735-005-9005-6, 16400526.
40. Qabar A, Nelson M, Guzman J, Corun C, Hwang BJ, Steinberg M. Modulation of sulfur mustard induced cell death in human epidermal keratinocytes using IL-10 and TNF-alpha. J Biochem Mol Toxicol 2005, 19:213-25. 10.1002/jbt.20089, 16173061.
41. Gambichler T, Tomi NS, Skrygan M, et al. Alterations of TGF-beta/Smad mRNA expression in atopic dermatitis following narrow-band ultraviolet B phototherapy: Results of a pilot study. J Dermatol Sci 2006, 44:56-8. 10.1016/j.jdermsci.2006.06.004, 16889943.
42. Antoni M, Fyhrquist-Vanni N, Wolff H, et al. Transforming growth factor-b/Smad3 signalling regulates inflammatory responses in a murine model of contact hypersensitivity. British J of Dermatology 2008, 159:546-554.
43. Anthoni M, Wang G, Deng C, Wolff HJ, Lauermaand AI, Alenius HT. Smad3 signal transducer regulates skin inflammation and specific IgE Response in murine model of atopic dermatitis. Journal of Investigative Dermatology 2007, 127:1923-1929. 10.1038/sj.jid.5700809, 17429443.
44. Koji S, et al. TGF-B/Smad signaling inhibits IFN-gamma and TNF-alpha-induced TARC(CCL17) production in HaCa cells. Journal of dermatological science 2003, 31(1):53-8. 10.1016/S0923-1811(02)00141-X, 12615364.
45. Crow MJ, Doetschman T, Greenhalgh DG. Delayed wound healing in immunodeficient TGF-B1 knockout mice. Journal of Investigative Dermatology 2000, 115:3-11. 10.1046/j.1523-1747.2000.00010.x, 10886500.
46. Matsuura H, Myokai F, Arata J, Noji S, Taniguchi S. Expression of type II transforming growth factor-β receptor mRNA in human skin, as revealed by in situ hybridization. J dermatol Sci 1994, 8:25-32. 10.1016/0923-1811(94)90317-4, 7947489.
47. Schimid P, Cox D, Bilbe G, McMaster G, Morrison C, Stahelin H, Luscher N, Seiler W. TGF-βs and TGF-β type II receptor in human epidermis: Differential expression in acute and chronic skin wounds. J pathol 1993, 171:191-197. 51 50, 10.1002/path.1711710307, 8277368.
48. Schmid P, Itin P, Cherry G, Bi C, Cox D. Enhanced expression of transforming growth factor-β type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol 1998, 152(2):485-493. 1857945, 9466575.
49. Schmid P, Itin P, Rufil TH. In situ analysis of transforming growth factors-β(TGF-β 1, TGF-β 2, TGF-β 3) and TGF-β type II receptor expression in basal cell carcinomas. Br j Dermatol 1996, 134:1044-1051. 10.1111/j.1365-2133.1996.tb07940.x, 8763422.
50. Sabourin CL, Danne MM, Buxton KL, Casillas RP, Schlager JJ. Cytokine, chemokine, and matrix metallo proteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 2002, 16:263-272. 10.1002/jbt.10050, 12481301.
51. Kuo YR, Wu WS, Jeng SF, Wang FS, Huang HC, Lin CZ, Yang KD. Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers Surg Med 2005, 36(1):38-42. 10.1002/lsm.20104, 15662627.
52. Glick AB, Kulkarni AB, Tennenbaum T, et al. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci USA 1993, 90(13):6076-6080. 10.1073/pnas.90.13.6076, 46870, 7687059.
53. He D, Wu Kim HK, et al. CD8 + IL-17-producing T cells are important in effector function for the elicitation of contact hypersensitivity responses. J Immunol 2006, 177:6852-8.
54. Veldhoen M, Hocking RJ, Atkins CJ, et al. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentation of IL-17-producing T cells. Immunity 2006, 24:179-89. 10.1016/j.immuni.2006.01.001, 16473830.
55. Ivanov II, McKenzie B, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentation program of proinflammatory IL-17 + T helper cells. Cell 2006, 126:1121-33. 10.1016/j.cell.2006.07.035, 16990136.
56. Schulze-Osthoff K, Bauer MK, Vogt M, Wesselborg S. Oxidative stress and signsl transduction. Int J Vitam Nytr Res 1997, 67:336-342.
57. Schwager J, Schulze J. Influence of ascorbic acid on the responce to mitogens and interleukin production of porcine lymphocytes. Int J Vitam Nutr Res 1997, 67:10-16.
58. Batova A, Danielpour D, Pirisi L, Creek KE. Retinoic acid induces secretion of latent transforming growth factor β1 and β2 in normal and human papillomavirus type 16-immortalized human keratinocytes. Cell Growth Differ 1992, 3:763-772.
59. Tong PS, Horowitz NN, Wheeler LA. Trans retinoic acid enhances the growth response of epidermal keratinocytes to epidermal growth factor and transforming growth factor beta. J Invest Dermatol 1990, 94(1):126-131. 10.1111/1523-1747.ep12873985, 2295827.
60. Creek KE, Geslani G, Batova A, Prisi L. Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-β at late stage of human papillomavirus type 16-initiated transformation of human keratinocytes. Advances in Experimental Medicine and Biology 1995, 375:117-135.
61. Koli K, Keski-Oja J. Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-beta 1 and beta 2 in cultured murine keratinocytes. Growth factors 1993, 8:153-163. 10.3109/08977199309046935, 8466756.
62. Lan CCE, et al. FK506 independently upregulates transforming growth factor β and downregulates inducible nitric oxide synthase in cultured human keratinocytes: possible mechanisms of how tacrolimus ointment interacts with atopic skin. Journal of Investigative Dermatology 2000, 115:3-11. 10.1046/j.1523-1747.2000.00010.x, 10886500.
63. Reitamo S, Wollenberg A, Schöpf E, Perrot SL, Marks R, Ruzicka T, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 2000, 136:999-1006. 10.1001/archderm.136.8.999, 10926735.